Technology

Securities Firms Maintain “Buy” Rating on Fosun International, Highlighting Significant Success in Business Streamlining Strategy and “Strategic Advancements and Exits”

Published

1 year ago

April 8, 2025

HONG KONG, April 8, 2025 /PRNewswire/ — Industrial Securities and Kaiyuan Securities recently published research reports highlighting Fosun International (00656.HK)’s accelerated exit from non-core assets and continued focus on core businesses. The reports stated that Fosun has increased its proportion of overseas revenue while maintaining overall stable revenue. Additionally, Fosun has continued to optimize its debt structure, with interest-bearing liabilities showing a downward trend. Both firms reaffirmed their respective “overweight” and “buy” ratings on Fosun International.

According to Fosun International’s 2024 annual results, the company has reported a total revenue of RMB192.14 billion. Its four core subsidiaries – Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group – generated a total revenue of RMB134.65 billion, accounting for 70.1% of the Group’s total revenue. Its industrial operation profit reached RMB4.9 billion. Excluding the significant one-off effect, the profit attributable to owners of the parent amounted to RMB750 million. Meanwhile, Fosun’s operating cash flow remained healthy and stable. The signed asset divestment amounted to approximately RMB17.5 billion equivalent at the group level, and approximately RMB30.0 billion equivalent at the consolidated level. As at the end of the Reporting Period, the Group’s total debt to total capital ratio was 52.0%, cash and bank balance and term deposits amounted to RMB106.34 billion.

Industrial Securities believes that by deeply cultivating the four major business segments of Health, Happiness, Wealth, and Intelligent Manufacturing, Fosun has accelerated its exit from non-core assets in recent years and optimized its capital structure to better focus on its core businesses. In 2024, it achieved orderly advancements and exits to enhance its asset portfolio, while continuously optimizing its debt structure, resulting in a downward trend in interest-bearing liabilities. At the same time, Fosun’s globalization capabilities were strengthened, and the development of overseas business became a highlight. In 2024, Fosun’s overseas revenue accounted for 49.3% of total revenue, with the overseas operations of core subsidiaries showing even stronger growth. For example, in 2024, Fosun Pharma’s revenue from regions and countries outside of the Chinese mainland reached RMB11.3 billion, representing a year-on-year increase of 8.9%; Fosun Insurance Portugal’s total gross written premiums from markets outside Portugal reached EUR1.84 billion, representing a year-on-year increase of 7.8%. As a result, Industrial Securities maintained an “overweight” rating on Fosun International.

Kaiyuan Securities also believes that Fosun’s overall revenue remains stable while the company continues to steadily exit non-core assets. At the same time, Fosun has placed a strong emphasis on ecosystem synergy to amplify the flywheel effect. It successfully implemented the “health care + insurance” ecosystem policy model, and Fosun Care achieved profitability for the first time. It also made significant progress in asset-light operations. For example, in 2024, Fosun Pharma together with the Shenzhen Guidance Fund and other investors established a RMB5.0 billion biopharmaceutical industry fund to jointly promote the high-quality development of the pharmaceutical and healthcare industry in the Greater Bay Area. Kaiyuan Securities is optimistic about Fosun’s focus on resource allocation in high-potential segments and its ongoing efforts to deepen global operations, thus maintaining a “buy” rating.

Fosun’s management stated at the results presentation that in the next few years, the Group aims to gradually increase the proportion of overseas revenue in its global operations; continue to divest from some asset-heavy projects to reduce financial leverage and maintain “strategic advancements and exits, and balanced investment and divestment”; progressively reduce the Group’s interest-bearing debts from the current level of more than RMB80 billion to RMB60 billion; strive to achieve RMB10 billion in industrial operation profit as well as in profit attributable to owners of the parent; and consistently enhance its operational capabilities, endeavoring to attain “investment grade” ratings.

Securities firms pointed out that Fosun’s success in its business streamlining strategy and “strategic advancements and exits” have been clearly reflected in its financial results. Moving forward, as the potential for growth in its core businesses is further unlocked and operational capabilities continue to improve, Fosun’s valuation and performance in the secondary market are expected to gradually return to a reasonable level. Data shows that as of 31 December 2024, Fosun International’s adjusted NAV was HK$17.6 per share, indicating a significant undervaluation compared to its current share price.

View original content:https://www.prnewswire.com/apac/news-releases/securities-firms-maintain-buy-rating-on-fosun-international-highlighting-significant-success-in-business-streamlining-strategy-and-strategic-advancements-and-exits-302423199.html

SOURCE Fosun

Technology

Yon Raz-Fridman Joins Intrinsic Labs as Co-Founder and Partner

Published

43 minutes ago

April 30, 2026

Most AI companies are selling software. Intrinsic is deploying AI workers into the core operations of mid-market companies – and just brought in a serial tech entrepreneur to help the firm scale across the Heartland.

COLUMBUS, Ohio, April 30, 2026 /PRNewswire/ — Intrinsic Labs today announced that Yon Raz-Fridman has joined the firm as a Co-Founder and Partner.

Raz-Fridman has spent nearly two decades building across software, hardware, and platform businesses. Early in his career, he served as Chief of Staff to the President of Keter Group, a $1 billion-plus global consumer products manufacturer. He went on to co-found Kano, the award-winning educational computing company, and later founded Supersocial, the immersive gaming studio acquired by Super League Enterprises in 2025. He is a member of the World Economic Forum’s Technology Convergence Council.

He joins Intrinsic at a moment when mid-market companies are moving from AI experimentation to deployment. Intrinsic works with operators in logistics, construction, insurance, manufacturing, and industrial markets to deploy AI workers into the workflows that run the business – increasing throughput, reducing manual work, and expanding capacity without adding headcount.

The firm has built its reputation on practical deployments tied to real operating metrics. In one engagement with a national real estate brokerage, Intrinsic’s AI Accounting Agents reached 97% invoice coding accuracy, automated 90% of the AP workflow, and fully removed FTEs from the review flow.

“Yon understands what it takes to build and scale in the real world,” said Jon Slemp, Managing Partner at Intrinsic Labs. “Our clients aren’t buying flashy agents, they’re buying outcomes and reliable labor. They need agentic systems that take work off their teams, perform reliably, and produce measurable gains in throughput and capacity. That’s what we build.”

As Co-Founder, Raz-Fridman will oversee Intrinsic’s expansion – designing the channel relationships, institutional partnerships, and market positioning that take the firm from a proven Ohio model to the defining AI workforce platform for America’s industrial middle market.

“The companies that win over the next decade will be the ones that figure out how to staff AI into their operations and manage it like a workforce. Intrinsic is doing that work now, inside real businesses, tied to real outputs. The Heartland is exactly the right place to prove this model, and Intrinsic is exactly the right team to do it.” — Yon Raz-Fridman

About Intrinsic Labs LLC
Intrinsic Labs helps mid-market companies deploy AI workers into the workflows that run their business. The firm focuses on logistics, construction, insurance, manufacturing, and industrial markets, where manual work, fragmented systems, and labor constraints create clear opportunities for leverage. Intrinsic works with clients to put AI workers into production, tie them to operating KPIs, and help teams scale output without scaling headcount. https://www.intrinsic-labs.ai/

About Team Yon LLC
Team Yon LLC is a management company founded by Yon Raz-Fridman that incubates new ventures, provides executive leadership, and makes strategic investments at the intersection of emerging technology and human advancement. Through Team Yon LLC, Raz-Fridman partners with founders and operators across healthcare, AI, and frontier technology – including his role as co-founder and Partner at Intrinsic Labs. https://teamyon.org

Media Contact:hello@intrinsic-labs.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/yon-raz-fridman-joins-intrinsic-labs-as-co-founder-and-partner-302756994.html

SOURCE Team Yon LLC

Technology

Wipfli to complete CompliancePoint transaction and add associates, expanding capabilities

Published

43 minutes ago

April 30, 2026

MILWAUKEE, April 30, 2026 /PRNewswire/ — Wipfli, a top 25 national advisory and accounting firm, announced today it has entered into an agreement with CompliancePoint Inc., a provider of risk management services focused on information security, data privacy and regulatory compliance. 2 partners and 52 associates will join the firm as a result of the transaction.

Based in Duluth, Georgia, CompliancePoint brings specialization across cybersecurity, privacy and compliance, serving clients across a wide variety of industries. The addition strengthens Wipfli’s risk management offerings and expands its ability to help organizations navigate regulatory scrutiny, evolving cybersecurity threats and complex data protection requirements.

“Organizations today are under more pressure than ever to protect sensitive information and operate responsibly in an evolving regulatory environment,” said Kurt Gresens, CEO at Wipfli Advisory, LLC. “The team at CompliancePoint brings specialized experience and a strong, people-first approach that enhances how we support clients navigating today’s risk landscape.”

CompliancePoint has built its reputation on helping organizations manage risk across the full data lifecycle, with a holistic approach that recognizes how privacy, security and compliance intersect. The combined professional teams from CompliancePoint and Wipfli will deliver expanded, integrated advisory solutions designed to help clients proactively manage risk while supporting long-term growth and operational resilience.

“Wipfli shares our commitment to practical, client-focused solutions and long-term relationships,” said Greg Sparrow, CompliancePoint president. “Together, we’re expanding the resources available to our clients while continuing to deliver the specialized experience and trusted relationships they rely on.”

The addition of the CompliancePoint team also supports Wipfli’s continued investment in talent and innovation. CompliancePoint associates will join a national firm that emphasizes collaboration, professional development and meaningful client impact, while maintaining the specialized focus that has defined their work.

The transaction is expected to become effective on May 1st, 2026

About Wipfli

Wipfli is a leading national advisory and accounting firm with nearly 100 years of experience serving ambitious middle-market organizations. We understand our clients’ unique challenges and help them succeed on their terms through assurance, tax, advisory, outsourcing and technology services. With 3,000+ associates and global alliances, we combine national capabilities with local relationships. Wipfli operates under an alternative practice structure: Wipfli LLP, a licensed CPA firm, provides attest services, while Wipfli Advisory LLC, a non-CPA firm, delivers business advisory and non-attest services. Learn more at wipfli.com or contact Alicia O’Connell at alicia.oconnell@wipfli.com.

Media Contact

Alicia O’Connell
Wipfli
alicia.oconnell@wipfli.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/wipfli-to-complete-compliancepoint-transaction-and-add-associates-expanding-capabilities-302756208.html

SOURCE Wipfli

Technology

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Published

43 minutes ago

April 30, 2026

Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026

BOSTON, April 30, 2026 /PRNewswire/ — Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”) today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2026, on Thursday, May 7, 2026, beginning at 4:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo’s investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. The company offers autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo’s in-house autonomous lab is also available as a “cloud lab” through our Datapoints and Solutions contract research services. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2026-results-presentation-302757632.html

SOURCE Ginkgo Bioworks